Jounce Therapeutics
Utility Patent Applications

Last updated:

List of all Jounce Therapeutics patents 13 in total

Status Patent
Application
Utility: Compositions and Methods for the Treatment of Cancer (Anti-ICOS Antibody Dosing) External link
Filling date: 6 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: Anti-ICOS Antibodies for the Treatment of Cancer External link
Filling date: 6 Sep 2025 Issue date: 5 May 2022
Application
Utility: METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES External link
Filling date: 6 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: Methods of Treating Cancer External link
Filling date: 6 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: Methods of Treating Cancer External link
Filling date: 6 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: Gene Signatures for Determining ICOS Expression External link
Filling date: 6 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: ANTIBODIES AND FUSION PROTEINS THAT BIND TO CCR8 AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: Antibodies to ICOS External link
Filling date: 6 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: Anti-PD-1 Antibodies and Uses Thereof External link
Filling date: 6 Sep 2025 Issue date: 24 Dec 2020
Application
Utility: ANTIBODIES TO LILRB2 External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: ANTIBODIES TO LILRB2 External link
Filling date: 6 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: Compositions and Methods for the Treatment of Cancer External link
Filling date: 6 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: METHODS OF TREATING CANCER External link
Filling date: 6 Sep 2025 Issue date: 5 Dec 2019

Showing 1 to 13 of 13 patents.